EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dopamine D2 receptor antagonist counteracts hyperglycemia and insulin resistance in diet-induced obese male mice

Dina I Vázquez-Carrillo, Ana Luisa Ocampo-Ruiz, Arelí Báez-Meza, Gabriela Ramírez-Hernández, Elva Adán-Castro, José Fernando García-Rodrigo, José Luis Dena-Beltrán, Ericka A de Los Ríos, Magdalena Karina Sánchez-Martínez, María Georgina Ortiz, Gonzalo Martínez de la Escalera, Carmen Clapp und 1 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0301496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Dina I Vázquez-Carrillo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, Querétaro, México. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 2, Hyperglycemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CONAHCYT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity leads to insulin resistance (IR) and type 2 diabetes. In humans, low levels of the hormone prolactin (PRL) correlate with IR, adipose tissue (AT) dysfunction, and increased prevalence of T2D. In obese rats, PRL treatment promotes insulin sensitivity and reduces visceral AT adipocyte hypertrophy. Here, we tested whether elevating PRL levels with the prokinetic and antipsychotic drug sulpiride, an antagonist of dopamine D2 receptors, improves metabolism in high fat diet (HFD)-induced obese male mice. Sulpiride treatment (30 days) reduced hyperglycemia, IR, and the serum and pancreatic levels of triglycerides in obese mice, reduced visceral and subcutaneous AT adipocyte hypertrophy, normalized markers of visceral AT function (PRL receptor, Glut4, insulin receptor and Hif-1α), and increased glycogen stores in skeletal muscle. However, the effects of sulpiride reducing hyperglycemia were also observed in obese prolactin receptor null mice. We conclude that sulpiride reduces obesity-induced hyperglycemia by mechanisms that are independent of prolactin/prolactin receptor activity. These findings support the therapeutic potential of sulpiride against metabolic dysfunction in obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceDiabetes Mellitus, Type 2HyperglycemiaHumansMiceMaleRatsAnimalsMice, ObeseDopamine D2 Receptor AntagonistsProlactinReceptors, ProlactinSulpirideObesityDiet, High-FatHypertrophyInsulin

Substanzen

Dopamine D2 Receptor AntagonistsProlactinReceptors, ProlactinSulpirideInsulin

Autor:innen und Institutionen

  • Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, Querétaro, México.

ORCID-Profile: Yazmín Macotela

Förderung

  • CONAHCYT

Zitieren

APA

Vázquez-Carrillo, D. I., Ocampo-Ruiz, A. L., Báez-Meza, A., Ramírez-Hernández, G., Adán-Castro, E., García-Rodrigo, J. F., Dena-Beltrán, J. L., de Los Ríos, E. A., Sánchez-Martínez, M. K., Ortiz, M. G., Martínez de la Escalera, G., Clapp, C., & Macotela, Y. (2024). Dopamine D2 receptor antagonist counteracts hyperglycemia and insulin resistance in diet-induced obese male mice. PLOS ONE. https://doi.org/10.1371/journal.pone.0301496

Vancouver

Vázquez-Carrillo DI, Ocampo-Ruiz AL, Báez-Meza A, Ramírez-Hernández G, Adán-Castro E, García-Rodrigo JF, et al. Dopamine D2 receptor antagonist counteracts hyperglycemia and insulin resistance in diet-induced obese male mice. PLOS ONE. 2024. doi:10.1371/journal.pone.0301496

BibTeX
@article{VzquezCarrillo2024,
  author = {Vázquez-Carrillo, Dina I and Ocampo-Ruiz, Ana Luisa and Báez-Meza, Arelí and Ramírez-Hernández, Gabriela and Adán-Castro, Elva and García-Rodrigo, José Fernando and Dena-Beltrán, José Luis and de Los Ríos, Ericka A and Sánchez-Martínez, Magdalena Karina and Ortiz, María Georgina and Martínez de la Escalera, Gonzalo and Clapp, Carmen and Macotela, Yazmín},
  title = {Dopamine D2 receptor antagonist counteracts hyperglycemia and insulin resistance in diet-induced obese male mice},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0301496}
}
Kostenlos starten →